vs

Side-by-side financial comparison of FREQUENCY ELECTRONICS INC (FEIM) and NEKTAR THERAPEUTICS (NKTR). Click either name above to swap in a different company.

NEKTAR THERAPEUTICS is the larger business by last-quarter revenue ($21.8M vs $17.1M, roughly 1.3× FREQUENCY ELECTRONICS INC). FREQUENCY ELECTRONICS INC runs the higher net margin — 10.5% vs -165.4%, a 176.0% gap on every dollar of revenue. On growth, FREQUENCY ELECTRONICS INC posted the faster year-over-year revenue change (8.3% vs -25.3%). FREQUENCY ELECTRONICS INC produced more free cash flow last quarter ($-1.1M vs $-65.0M). Over the past eight quarters, FREQUENCY ELECTRONICS INC's revenue compounded faster (11.8% CAGR vs 0.4%).

Ultra Electronics Holdings is a British defence and security company. It was listed on the London Stock Exchange and was a constituent of the FTSE 250 Index until it was acquired by Cobham, which is itself owned by Advent International.

Nektar Therapeutics is an American biopharmaceutical company. The company was founded in 1990 and is based in San Francisco, California. The company develops new drug candidates by applying its proprietary PEGylation and advanced polymer conjugate technologies to modify chemical structure of substances, which improves drug characteristics like retention and solubility. It is a technology supplier to a number of pharmaceutical companies including Affymax, Amgen, Merck, Pfizer and UCB Pharma, e...

FEIM vs NKTR — Head-to-Head

Bigger by revenue
NKTR
NKTR
1.3× larger
NKTR
$21.8M
$17.1M
FEIM
Growing faster (revenue YoY)
FEIM
FEIM
+33.5% gap
FEIM
8.3%
-25.3%
NKTR
Higher net margin
FEIM
FEIM
176.0% more per $
FEIM
10.5%
-165.4%
NKTR
More free cash flow
FEIM
FEIM
$63.8M more FCF
FEIM
$-1.1M
$-65.0M
NKTR
Faster 2-yr revenue CAGR
FEIM
FEIM
Annualised
FEIM
11.8%
0.4%
NKTR

Income Statement — Q2 FY2026 vs Q4 FY2025

Metric
FEIM
FEIM
NKTR
NKTR
Revenue
$17.1M
$21.8M
Net Profit
$1.8M
$-36.1M
Gross Margin
38.2%
Operating Margin
10.0%
-126.9%
Net Margin
10.5%
-165.4%
Revenue YoY
8.3%
-25.3%
Net Profit YoY
-32.1%
-596.9%
EPS (diluted)
$0.18
$-4.67

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FEIM
FEIM
NKTR
NKTR
Q4 25
$17.1M
$21.8M
Q3 25
$13.8M
$11.8M
Q2 25
$20.0M
$11.2M
Q1 25
$18.9M
$10.5M
Q4 24
$15.8M
$29.2M
Q3 24
$15.1M
$24.1M
Q2 24
$15.6M
$23.5M
Q1 24
$13.7M
$21.6M
Net Profit
FEIM
FEIM
NKTR
NKTR
Q4 25
$1.8M
$-36.1M
Q3 25
$634.0K
$-35.5M
Q2 25
$3.2M
$-41.6M
Q1 25
$15.4M
$-50.9M
Q4 24
$2.7M
$7.3M
Q3 24
$2.4M
$-37.1M
Q2 24
$2.6M
$-52.4M
Q1 24
$130.0K
$-36.8M
Gross Margin
FEIM
FEIM
NKTR
NKTR
Q4 25
38.2%
Q3 25
36.8%
Q2 25
37.5%
Q1 25
43.8%
Q4 24
48.2%
72.7%
Q3 24
44.4%
81.6%
Q2 24
40.3%
58.5%
Q1 24
22.6%
60.6%
Operating Margin
FEIM
FEIM
NKTR
NKTR
Q4 25
10.0%
-126.9%
Q3 25
2.6%
-268.6%
Q2 25
16.4%
-324.2%
Q1 25
18.3%
-425.8%
Q4 24
16.5%
49.2%
Q3 24
15.7%
-142.4%
Q2 24
16.0%
-211.9%
Q1 24
-3.4%
-163.7%
Net Margin
FEIM
FEIM
NKTR
NKTR
Q4 25
10.5%
-165.4%
Q3 25
4.6%
-301.3%
Q2 25
16.0%
-372.2%
Q1 25
81.4%
-486.4%
Q4 24
16.8%
24.9%
Q3 24
16.1%
-153.6%
Q2 24
16.9%
-222.9%
Q1 24
0.9%
-170.1%
EPS (diluted)
FEIM
FEIM
NKTR
NKTR
Q4 25
$0.18
$-4.67
Q3 25
$0.07
$-1.87
Q2 25
$0.33
$-2.95
Q1 25
$1.60
$-0.24
Q4 24
$0.28
$-2.07
Q3 24
$0.25
$-2.66
Q2 24
$0.28
$-3.76
Q1 24
$0.01
$-0.19

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FEIM
FEIM
NKTR
NKTR
Cash + ST InvestmentsLiquidity on hand
$3.0M
$15.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$58.5M
$89.8M
Total Assets
$92.3M
$280.4M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FEIM
FEIM
NKTR
NKTR
Q4 25
$3.0M
$15.1M
Q3 25
$4.5M
$41.0M
Q2 25
$4.7M
$43.0M
Q1 25
$5.5M
$38.9M
Q4 24
$9.7M
$44.3M
Q3 24
$16.2M
$30.1M
Q2 24
$18.3M
$27.9M
Q1 24
$11.7M
$48.6M
Stockholders' Equity
FEIM
FEIM
NKTR
NKTR
Q4 25
$58.5M
$89.8M
Q3 25
$56.3M
$85.1M
Q2 25
$55.6M
$-24.2M
Q1 25
$51.8M
$13.7M
Q4 24
$36.2M
$60.7M
Q3 24
$33.2M
$48.9M
Q2 24
$39.8M
$79.7M
Q1 24
$36.7M
$126.7M
Total Assets
FEIM
FEIM
NKTR
NKTR
Q4 25
$92.3M
$280.4M
Q3 25
$93.2M
$301.3M
Q2 25
$93.7M
$207.5M
Q1 25
$86.4M
$256.2M
Q4 24
$77.8M
$303.9M
Q3 24
$84.3M
$308.0M
Q2 24
$83.3M
$343.3M
Q1 24
$77.7M
$396.0M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FEIM
FEIM
NKTR
NKTR
Operating Cash FlowLast quarter
$-523.0K
$-65.0M
Free Cash FlowOCF − Capex
$-1.1M
$-65.0M
FCF MarginFCF / Revenue
-6.6%
-298.0%
Capex IntensityCapex / Revenue
3.6%
0.1%
Cash ConversionOCF / Net Profit
-0.29×
TTM Free Cash FlowTrailing 4 quarters
$-5.5M
$-208.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FEIM
FEIM
NKTR
NKTR
Q4 25
$-523.0K
$-65.0M
Q3 25
$1.2M
$-48.8M
Q2 25
$-155.0K
$-45.7M
Q1 25
$-3.6M
$-49.1M
Q4 24
$3.8M
$-46.2M
Q3 24
$-1.5M
$-43.9M
Q2 24
$7.5M
$-37.7M
Q1 24
$4.2M
$-47.9M
Free Cash Flow
FEIM
FEIM
NKTR
NKTR
Q4 25
$-1.1M
$-65.0M
Q3 25
$385.0K
$-48.9M
Q2 25
$-786.0K
$-45.8M
Q1 25
$-4.0M
$-49.1M
Q4 24
$3.3M
$-46.6M
Q3 24
$-1.8M
$-44.6M
Q2 24
$6.7M
$-37.9M
Q1 24
$3.9M
$-48.0M
FCF Margin
FEIM
FEIM
NKTR
NKTR
Q4 25
-6.6%
-298.0%
Q3 25
2.8%
-414.5%
Q2 25
-3.9%
-409.6%
Q1 25
-20.9%
-469.0%
Q4 24
20.8%
-159.9%
Q3 24
-11.8%
-184.9%
Q2 24
42.8%
-161.3%
Q1 24
28.4%
-222.0%
Capex Intensity
FEIM
FEIM
NKTR
NKTR
Q4 25
3.6%
0.1%
Q3 25
5.6%
1.0%
Q2 25
3.2%
0.3%
Q1 25
1.7%
0.0%
Q4 24
3.3%
1.6%
Q3 24
2.2%
2.8%
Q2 24
5.3%
0.8%
Q1 24
2.3%
0.7%
Cash Conversion
FEIM
FEIM
NKTR
NKTR
Q4 25
-0.29×
Q3 25
1.83×
Q2 25
-0.05×
Q1 25
-0.24×
Q4 24
1.44×
-6.36×
Q3 24
-0.60×
Q2 24
2.85×
Q1 24
32.36×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FEIM
FEIM

POC Revenue$14.8M86%
POT Revenue$2.3M13%

NKTR
NKTR

Segment breakdown not available.

Related Comparisons